Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 18 | 2024 | 521 | 5.500 |
Why?
|
Tomography, Optical Coherence | 28 | 2024 | 2954 | 3.910 |
Why?
|
Lung Diseases, Interstitial | 8 | 2024 | 940 | 2.470 |
Why?
|
Lung | 30 | 2024 | 10076 | 2.160 |
Why?
|
Bronchoscopy | 9 | 2024 | 913 | 2.090 |
Why?
|
Pathology | 4 | 2020 | 270 | 1.960 |
Why?
|
Microscopy | 5 | 2019 | 903 | 1.740 |
Why?
|
Pulmonary Fibrosis | 10 | 2024 | 505 | 1.710 |
Why?
|
Lung Diseases | 6 | 2022 | 1942 | 1.250 |
Why?
|
Lung Neoplasms | 20 | 2024 | 13491 | 0.980 |
Why?
|
Dyspnea | 3 | 2021 | 1352 | 0.850 |
Why?
|
Cough | 3 | 2022 | 598 | 0.790 |
Why?
|
Spectrometry, Fluorescence | 3 | 2010 | 694 | 0.760 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.730 |
Why?
|
Hemosiderosis | 1 | 2021 | 66 | 0.730 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 61 | 0.690 |
Why?
|
Lung Injury | 2 | 2023 | 432 | 0.670 |
Why?
|
Pathology, Surgical | 2 | 2018 | 147 | 0.600 |
Why?
|
Biopsy | 9 | 2023 | 6777 | 0.570 |
Why?
|
Fibrosis | 7 | 2024 | 2078 | 0.570 |
Why?
|
Bronchiectasis | 1 | 2018 | 141 | 0.560 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 453 | 0.540 |
Why?
|
Prednisone | 1 | 2021 | 1566 | 0.530 |
Why?
|
Sputum | 1 | 2018 | 514 | 0.520 |
Why?
|
Pathology, Clinical | 5 | 2017 | 374 | 0.500 |
Why?
|
Alveolitis, Extrinsic Allergic | 2 | 2017 | 62 | 0.500 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20741 | 0.500 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7435 | 0.480 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3530 | 0.470 |
Why?
|
Precancerous Conditions | 1 | 2021 | 980 | 0.450 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 265 | 0.430 |
Why?
|
Influenza, Human | 2 | 2023 | 1543 | 0.420 |
Why?
|
Pneumonia | 3 | 2022 | 2159 | 0.420 |
Why?
|
Calcinosis | 1 | 2021 | 1481 | 0.410 |
Why?
|
Amyloidosis | 1 | 2020 | 876 | 0.390 |
Why?
|
Esophageal Diseases | 1 | 2012 | 167 | 0.380 |
Why?
|
Glucocorticoids | 1 | 2021 | 2163 | 0.380 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2023 | 4049 | 0.380 |
Why?
|
Silicones | 1 | 2012 | 228 | 0.360 |
Why?
|
Lasers | 4 | 2010 | 951 | 0.350 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2013 | 281 | 0.340 |
Why?
|
Professional Role | 1 | 2012 | 315 | 0.330 |
Why?
|
Humans | 78 | 2024 | 767040 | 0.330 |
Why?
|
Cystic Fibrosis | 1 | 2018 | 1292 | 0.320 |
Why?
|
Diagnosis, Differential | 7 | 2021 | 12986 | 0.310 |
Why?
|
Respiratory System | 3 | 2023 | 563 | 0.310 |
Why?
|
Disease Models, Animal | 8 | 2024 | 18330 | 0.290 |
Why?
|
Hemorrhage | 1 | 2019 | 3464 | 0.290 |
Why?
|
Optics and Photonics | 1 | 2009 | 305 | 0.290 |
Why?
|
Tomography | 2 | 2009 | 443 | 0.280 |
Why?
|
Epithelial Cells | 6 | 2024 | 3698 | 0.270 |
Why?
|
Adenocarcinoma | 2 | 2015 | 6360 | 0.260 |
Why?
|
Thrombosis | 1 | 2020 | 2954 | 0.260 |
Why?
|
Ovary | 1 | 2010 | 965 | 0.260 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Bronchi | 3 | 2021 | 847 | 0.230 |
Why?
|
Societies, Medical | 7 | 2021 | 3964 | 0.220 |
Why?
|
Middle Aged | 19 | 2024 | 223233 | 0.220 |
Why?
|
2-Aminoadipic Acid | 1 | 2023 | 32 | 0.220 |
Why?
|
Ovarian Neoplasms | 2 | 2010 | 4903 | 0.210 |
Why?
|
Aldehydes | 1 | 2023 | 170 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 391 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
Bleomycin | 5 | 2022 | 492 | 0.200 |
Why?
|
Tretinoin | 2 | 2024 | 524 | 0.190 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.190 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.190 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.180 |
Why?
|
Aged | 13 | 2024 | 171319 | 0.180 |
Why?
|
Respiratory Mucosa | 1 | 2024 | 437 | 0.180 |
Why?
|
Pulmonary Alveoli | 2 | 2022 | 665 | 0.180 |
Why?
|
Capillary Permeability | 2 | 2022 | 772 | 0.180 |
Why?
|
Male | 22 | 2024 | 364203 | 0.180 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 268 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.170 |
Why?
|
Splenomegaly | 1 | 2020 | 191 | 0.170 |
Why?
|
Organometallic Compounds | 1 | 2023 | 648 | 0.170 |
Why?
|
Mucociliary Clearance | 1 | 2020 | 81 | 0.170 |
Why?
|
X-Ray Microtomography | 2 | 2020 | 456 | 0.170 |
Why?
|
Female | 24 | 2024 | 396660 | 0.170 |
Why?
|
Mice | 19 | 2024 | 81912 | 0.160 |
Why?
|
Microscopy, Polarization | 1 | 2019 | 88 | 0.160 |
Why?
|
Pseudomonas Infections | 1 | 2023 | 623 | 0.160 |
Why?
|
Mycobacterium avium Complex | 1 | 2018 | 66 | 0.160 |
Why?
|
Asthma | 4 | 2023 | 6268 | 0.160 |
Why?
|
Adenoma | 2 | 2007 | 2155 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 3370 | 0.160 |
Why?
|
Animals | 29 | 2024 | 168965 | 0.150 |
Why?
|
Collagen Type I | 2 | 2023 | 617 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 1205 | 0.150 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2021 | 616 | 0.150 |
Why?
|
Infarction | 1 | 2019 | 247 | 0.150 |
Why?
|
Coronary Disease | 1 | 2012 | 5914 | 0.150 |
Why?
|
Physical Exertion | 1 | 2021 | 667 | 0.150 |
Why?
|
Respiratory Function Tests | 2 | 2019 | 1695 | 0.150 |
Why?
|
Airway Remodeling | 1 | 2019 | 133 | 0.150 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2160 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1150 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2024 | 492 | 0.140 |
Why?
|
Respiratory Hypersensitivity | 1 | 2019 | 271 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2902 | 0.140 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20169 | 0.140 |
Why?
|
Colorectal Neoplasms | 2 | 2007 | 6966 | 0.140 |
Why?
|
Muscle, Smooth | 2 | 2021 | 930 | 0.140 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 453 | 0.140 |
Why?
|
Fibroblasts | 2 | 2024 | 4167 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 283 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1196 | 0.130 |
Why?
|
Consensus | 2 | 2024 | 3207 | 0.130 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 346 | 0.130 |
Why?
|
Endoscopy | 1 | 2006 | 1854 | 0.130 |
Why?
|
Opportunistic Infections | 1 | 2018 | 375 | 0.130 |
Why?
|
Eye | 1 | 2020 | 711 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5389 | 0.130 |
Why?
|
Molecular Probes | 1 | 2017 | 309 | 0.120 |
Why?
|
Allergens | 2 | 2023 | 1436 | 0.120 |
Why?
|
Giant Cell Tumors | 1 | 2015 | 89 | 0.120 |
Why?
|
Regeneration | 1 | 2024 | 1523 | 0.120 |
Why?
|
Observer Variation | 1 | 2021 | 2616 | 0.120 |
Why?
|
Cell Differentiation | 5 | 2023 | 11657 | 0.120 |
Why?
|
Colon | 3 | 2007 | 1797 | 0.120 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6550 | 0.120 |
Why?
|
Peritoneal Neoplasms | 1 | 2020 | 706 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1131 | 0.110 |
Why?
|
Radiology, Interventional | 1 | 2018 | 483 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2023 | 1169 | 0.110 |
Why?
|
Pulvinar | 1 | 2013 | 24 | 0.110 |
Why?
|
Pilot Projects | 4 | 2018 | 8732 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2017 | 768 | 0.110 |
Why?
|
Mucin-1 | 1 | 2018 | 536 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2144 | 0.110 |
Why?
|
Commerce | 1 | 2018 | 614 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 1003 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2018 | 523 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1320 | 0.110 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2007 | 2441 | 0.100 |
Why?
|
Endothelial Cells | 3 | 2022 | 3582 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 610 | 0.100 |
Why?
|
Adult Stem Cells | 1 | 2014 | 221 | 0.100 |
Why?
|
Heterozygote | 1 | 2018 | 2794 | 0.100 |
Why?
|
Collagen | 4 | 2024 | 2636 | 0.100 |
Why?
|
Inflammation | 3 | 2024 | 10869 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11063 | 0.090 |
Why?
|
Stem Cells | 1 | 2024 | 3535 | 0.090 |
Why?
|
Cyclohexenes | 1 | 2010 | 15 | 0.090 |
Why?
|
Vinyl Compounds | 1 | 2010 | 21 | 0.090 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2010 | 58 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3440 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1741 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2016 | 1560 | 0.090 |
Why?
|
Hamartoma | 1 | 2013 | 235 | 0.090 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 685 | 0.090 |
Why?
|
Contrast Media | 1 | 2023 | 5329 | 0.090 |
Why?
|
Disease Progression | 5 | 2020 | 13646 | 0.090 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.090 |
Why?
|
Gallium Radioisotopes | 2 | 2023 | 195 | 0.090 |
Why?
|
Phosphoproteins | 2 | 2020 | 2448 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3114 | 0.080 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2010 | 108 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59548 | 0.080 |
Why?
|
Colonoscopes | 2 | 2006 | 17 | 0.080 |
Why?
|
Laparoscopes | 1 | 2009 | 36 | 0.080 |
Why?
|
Sinusitis | 1 | 2018 | 997 | 0.080 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 820 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 949 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2013 | 748 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2575 | 0.080 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2010 | 117 | 0.080 |
Why?
|
Antiphospholipid Syndrome | 1 | 2010 | 166 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2024 | 22254 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1615 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3464 | 0.080 |
Why?
|
Trachea | 1 | 2014 | 1095 | 0.070 |
Why?
|
Transsexualism | 1 | 2012 | 210 | 0.070 |
Why?
|
Status Epilepticus | 1 | 2013 | 459 | 0.070 |
Why?
|
Azoxymethane | 1 | 2007 | 32 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2824 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1661 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1481 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4052 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22361 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2016 | 1310 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3779 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3468 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14672 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2015 | 1424 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5785 | 0.060 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2006 | 182 | 0.060 |
Why?
|
Young Adult | 3 | 2021 | 59980 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
HIV Infections | 1 | 2012 | 17542 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3249 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15424 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1765 | 0.060 |
Why?
|
Dogs | 2 | 2021 | 3834 | 0.060 |
Why?
|
Graft Rejection | 1 | 2016 | 4498 | 0.050 |
Why?
|
Metaplasia | 1 | 2024 | 326 | 0.050 |
Why?
|
Paroxetine | 1 | 2024 | 181 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8940 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 230 | 0.050 |
Why?
|
Endoscopes | 1 | 2004 | 169 | 0.050 |
Why?
|
Swine | 1 | 2013 | 5987 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 325 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36582 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 299 | 0.050 |
Why?
|
Up-Regulation | 2 | 2021 | 4143 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 262 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
Endothelium | 1 | 2024 | 768 | 0.050 |
Why?
|
Immunity, Innate | 2 | 2023 | 3076 | 0.050 |
Why?
|
Rats | 2 | 2023 | 23713 | 0.050 |
Why?
|
Signal Transduction | 5 | 2024 | 23621 | 0.050 |
Why?
|
Vitamin A | 1 | 2024 | 611 | 0.050 |
Why?
|
Esophagus | 1 | 2007 | 1041 | 0.050 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 888 | 0.050 |
Why?
|
Intestine, Small | 1 | 2007 | 1217 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54886 | 0.040 |
Why?
|
Adult | 7 | 2021 | 223317 | 0.040 |
Why?
|
United States | 4 | 2024 | 72971 | 0.040 |
Why?
|
Acyl Coenzyme A | 1 | 2020 | 56 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2023 | 823 | 0.040 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2020 | 110 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1969 | 0.040 |
Why?
|
Mevalonic Acid | 1 | 2020 | 46 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1252 | 0.040 |
Why?
|
Mutation | 3 | 2020 | 30211 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 998 | 0.040 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2007 | 957 | 0.040 |
Why?
|
Sphingosine | 1 | 2022 | 306 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2020 | 241 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2023 | 2275 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2022 | 336 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6975 | 0.040 |
Why?
|
Bronchial Provocation Tests | 1 | 2019 | 215 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 2628 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 57 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2022 | 9551 | 0.040 |
Why?
|
Endovascular Procedures | 1 | 2012 | 2215 | 0.040 |
Why?
|
Refraction, Ocular | 1 | 2020 | 188 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10455 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 964 | 0.040 |
Why?
|
Hematoxylin | 1 | 2018 | 61 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2018 | 70 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2019 | 697 | 0.040 |
Why?
|
Norepinephrine | 1 | 2021 | 898 | 0.040 |
Why?
|
Prognosis | 4 | 2020 | 29963 | 0.040 |
Why?
|
Simvastatin | 1 | 2020 | 345 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 165 | 0.040 |
Why?
|
Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2023 | 822 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2024 | 1281 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 24299 | 0.030 |
Why?
|
Muscle Relaxation | 1 | 2016 | 138 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2018 | 545 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2867 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2605 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2022 | 1163 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2019 | 450 | 0.030 |
Why?
|
Cytoplasm | 1 | 2020 | 1504 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1671 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 430 | 0.030 |
Why?
|
Pulmonary Medicine | 1 | 2017 | 223 | 0.030 |
Why?
|
Homozygote | 1 | 2020 | 1774 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2021 | 65295 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 742 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4282 | 0.030 |
Why?
|
HIV-1 | 1 | 2012 | 6951 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1717 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5311 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 872 | 0.030 |
Why?
|
Gene Deletion | 1 | 2022 | 2668 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2535 | 0.030 |
Why?
|
Equipment Failure Analysis | 2 | 2006 | 832 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1076 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 1995 | 0.030 |
Why?
|
Equipment Design | 3 | 2006 | 3489 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 722 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16718 | 0.030 |
Why?
|
Cartilage | 1 | 2016 | 811 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3611 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2016 | 1208 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3934 | 0.020 |
Why?
|
Myocardium | 1 | 2024 | 4765 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2020 | 2875 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2538 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3913 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6014 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1890 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2021 | 18989 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1733 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5891 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
Child | 2 | 2020 | 80771 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2800 | 0.020 |
Why?
|
Adolescent | 2 | 2020 | 89046 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3944 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5796 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3610 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5203 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5332 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11217 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8628 | 0.020 |
Why?
|
Tomography, Optical | 1 | 2006 | 129 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7469 | 0.020 |
Why?
|
Trans-Activators | 1 | 2014 | 2856 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15567 | 0.010 |
Why?
|
Systems Integration | 1 | 2006 | 425 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2006 | 486 | 0.010 |
Why?
|
Gelatin | 1 | 2006 | 227 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18401 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12823 | 0.010 |
Why?
|
Surface Properties | 1 | 2006 | 1154 | 0.010 |
Why?
|
Microspheres | 1 | 2006 | 774 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14476 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7063 | 0.010 |
Why?
|
Coloring Agents | 1 | 2004 | 565 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11923 | 0.010 |
Why?
|
Cattle | 1 | 2006 | 3813 | 0.010 |
Why?
|
Light | 1 | 2006 | 1358 | 0.010 |
Why?
|
Immunotherapy | 1 | 2016 | 4745 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26325 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12158 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10254 | 0.010 |
Why?
|
Aorta | 1 | 2006 | 2045 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2006 | 2487 | 0.010 |
Why?
|
Artifacts | 1 | 2006 | 1904 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74886 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27163 | 0.010 |
Why?
|
Colonoscopy | 1 | 2004 | 1409 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18063 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9517 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5098 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81659 | 0.010 |
Why?
|
Algorithms | 1 | 2006 | 14098 | 0.000 |
Why?
|